Stifel Upgrades Fulcrum Therapeutics (FULC) to Buy, PT $11, 'Resolution To FTX-6058 Clinical Hold Reintroduces Important Value Driver'
Tweet Send to a Friend
(Updated - August 22, 2023 7:23 AM EDT)
Stifel analyst Dae Gon Ha upgraded Fulcrum Therapeutics (NASDAQ: FULC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Dae Gon Ha upgraded Fulcrum Therapeutics (NASDAQ: FULC) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
